Get started
Author

Michel Janicot

JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
2009 · Janine Arts, Peter King, et al. · Clinical Cancer Research · 231
Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles
2004 · Suzie H. Pun, Frederik Tack, et al. · Cancer Biology & Therapy · 200
PDF
Critical Role of the Ubiquitin Ligase Activity of UHRF1, a Nuclear RING Finger Protein, in Tumor Cell Growth
2005 · Yonchu Jenkins, Vadim Markovtsov, et al. · Molecular Biology of the Cell · 184
Disruption of Murine Mus81 Increases Genomic Instability and DNA Damage Sensitivity but Does Not Promote Tumorigenesis
2005 · Najoua Dendouga, Hui Gao, et al. · Molecular and Cellular Biology · 146
Promoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes.
1992 · A G Swick, M Janicot, et al. · Proceedings of the National Academy of Sciences · 115
R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies
2007 · J Arts, P Angibaud, et al. · British Journal of Cancer · 89
PDF
Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes)
2006 · Frederik Tack, Annette Bakker, et al. · Journal of drug targeting · 89
Housekeeping Genes as Internal Standards in Cancer Research
2004 · Nico Janssens, Michel Janicot, et al. · Molecular Diagnosis · 89
Transcriptional repression of the mouse insulin-responsive glucose transporter (GLUT4) gene by cAMP.
1991 · K H Kaestner, J R Flores-Riveros, et al. · Proceedings of the National Academy of Sciences · 89
Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity
2002 · J Van heusden, R Van Ginckel, et al. · British Journal of Cancer · 86
PDF
Inhibition of Histone Deacetylases by Chlamydocin Induces Apoptosis and Proteasome-Mediated Degradation of Survivin
2003 · Stefanie De Schepper, Hélène Bruwiere, et al. · Journal of Pharmacology and Experimental Therapeutics · 82
Design and Analysis of Drug Combination Experiments
2005 · Roel Straetemans, Timothy O'Brien, et al. · Biometrical Journal · 78
The Wnt-dependent signaling pathways as target in oncology drug discovery
2006 · Nico Janssens, Michel Janicot, et al. · Investigational New Drugs · 72
PDF
TGF-β1 and TGF-β2 abundance in liver diseases of mice and men
2016 · Anne Dropmann, Tatjana Dediulia, et al. · Oncotarget · 66
PDF
Biological Role and Therapeutic Targeting of TGF-β3 in Glioblastoma
2017 · Katharina Seystahl, Alexandros Papachristodoulou, et al. · Molecular Cancer Therapeutics · 60
PDF
Activation of rat liver adenylate cyclase by cholera toxin requires toxin internalization and processing in endosomes
1991 · M. Janicot, F. Fouque, et al. · Journal of Biological Chemistry · 55
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental Gliomas
2019 · Alexandros Papachristodoulou, Manuela Silginer, et al. · Clinical Cancer Research · 52
PDF
Alteration of Frizzled Expression in Renal Cell Carcinoma
2004 · Nico Janssens, Luc Andries, et al. · Tumor Biology · 43
TGF-β2 silencing to target biliary-derived liver diseases
2020 · Anne Dropmann, Steven Dooley, et al. · Gut · 42
PDF
Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology
2021 · Bryony J. Telford, Sanaz Yahyanejad, et al. · Oncotarget · 41
PDF
Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment.
1999 · J S Russell, F F Lang, et al. · PubMed · 38
Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors
2003 · Patrick Angibaud, Xavier Bourdrez, et al. · Bioorganic & Medicinal Chemistry Letters · 30
Insulin-Receptor Tyrosine Kinase and Glucose Transport
1990 · M Daniel Lane, Jaime R Flores-Riveros, et al. · Diabetes Care · 30
An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages
2017 · I. Huber-Ruano, C. Raventós, et al. · Annals of Oncology · 29
PDF
Fate of injected 125I‐labeled cholera toxin taken up by rat liver in vivo
1987 · Michel JANICOT, Bernard DESBUQUOIS · European Journal of Biochemistry · 28
PDF
Works count: 114
Citation count: 2,341
H-index: 26
I10-index: 38
Year
Topic
Type